BioSpace News Archive

PharmaTher Announces Positive Topline Results from Clinical Study of Ketamine for Parkinson’s Disease

PharmaTher Holdings Ltd. is pleased to announce positive topline results from the dose-finding and tolerability clinical study (the “Study”) of ketamine for the treatment of levodopa-induced dyskinesia (“LID”) in patients with Parkinson’s disease.

March 23, 2022
·
8 min read
XORTX Files New PCT Patent to Treat and Protect Individuals Most at Risk to Severe Viral InfectionCompositions and Methods for Enhancing Anti-Viral Therapies

XORTX Therapeutics Inc. announces the submission of a Patent Cooperation Treaty (PCT) patent application seeking international patent protection for the patent entitled “Compositions and Methods for Enhancing Anti-Viral Therapies”.

March 23, 2022
·
5 min read
Business

VBL Therapeutics Reports Full Year 2021 Financial Results and Provides Corporate Update

VBL Therapeutics today announced financial results for the fiscal year ended December 31, 2021, and provided a corporate update.

March 23, 2022
·
9 min read
Biotech Beach

Innova SARS-CoV-2 Antigen Test Receives CE Mark for Self-Testing

Innova Medical Group, Inc., a global health screening and diagnostic innovator and a world leader in the manufacture and distribution of COVID-19 rapid tests, announced that the Innova SARS-CoV-2 Antigen Rapid Qualitative Test has received a CE Mark for self-testing.

March 23, 2022
·
2 min read
Business

Silence Therapeutics and Mallinckrodt Announce Submission of Clinical Trial Application for SLN501

Silence Therapeutics plc and Mallinckrodt plc today announced filing of a clinical trial application (CTA) for SLN501, an siRNA targeting the complement C3 protein, triggering a $3 million milestone payment to Silence.

March 23, 2022
·
6 min read
Business

Zynex Recognized as Fourth Largest Biotechnology/Bioscience Company in Colorado

Zynex, Inc today announced the Denver Business Journal has recognized Zynex as the fourth largest Biotechnology/Bioscience public company.

March 23, 2022
·
3 min read
Insulin Pump Market Size to Reach US$ 10.31 Billion by 2028

According to Precedence Research, the insulin pump market size is expected to reach over US$ 10.31 billion by 2028 and growing at a CAGR of 13.5% over the forecast period 2021 to 2030.

March 23, 2022
·
4 min read
Cardiovascular Devices Market Size to Worth Around US$ 81.51 BN by 2028

As per Precedence Research, the cardiovascular devices market size is projected to be worth around US$ 81.51 billion by 2028 growing at a CAGR of 6.4% over the forecast period 2021 to 2030.

March 23, 2022
·
4 min read
Conjunctivitis Market Size to Reach US$ 5.85 Billion by 2028

As per Precedence Research, the global conjunctivitis market size is expected to reach US$ 5.85 billion by 2028, expanding growth at a CAGR of 3.65% over the forecast period 2022 to 2030.

March 23, 2022
·
5 min read
CRISPR &Cas Genes Market to Hit US$ 4.23 Billion by 2027

The CRISPR & Cas genes market size is expected to hit US$ 4.23 billion by 2027 and is growing at a CAGR of around 16.1% from 2021 to 2027, according to report study by Precedence Research.

March 23, 2022
·
4 min read